Jpmorgan Chase & CO Biomarin Pharmaceutical Inc Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 2,811,789 shares of BMRN stock, worth $176 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,811,789

Previous 2,593,181 8.43%

Holding current value

$176 Million

Previous $213 Million 7.43%

% of portfolio

0.02%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$69.02 - $93.84 $15.1 Million - $20.5 Million	218,608 Added 8.43%	2,811,789 $198 Million
Q2 2024 Aug 12, 2024	BUY	$74.43 - $92.22 $12.7 Million - $15.8 Million	171,179 Added 7.07%	2,593,181 $213 Million
Q1 2024 May 10, 2024	SELL	$83.81 - $99.0 $2.16 Million - $2.55 Million	-25,790 Reduced 1.05%	2,422,002 $212 Million
Q4 2023 Feb 12, 2024	SELL	$76.22 - $98.51 $13 Million - $16.8 Million	-171,040 Reduced 6.53%	2,447,792 $236 Million
Q3 2023 Nov 14, 2023	BUY	$85.07 - $94.48 $639,301 - $710,017	7,515 Added 0.29%	2,618,832 $232 Million
Q2 2023 Aug 11, 2023	BUY	$86.68 - $100.3 $4.97 Million - $5.76 Million	57,391 Added 2.25%	2,611,317 $226 Million
Q1 2023 May 18, 2023	BUY	$87.74 - $117.27 $674,106 - $900,985	7,683 Added 0.3%	2,553,926 $248 Million
Q1 2023 May 11, 2023	SELL	$87.74 - $117.27 $1.26 Million - $1.69 Million	-14,401 Reduced 0.56%	2,546,243 $248 Million
Q4 2022 Feb 13, 2023	BUY	$80.93 - $108.63 $41 Million - $55 Million	506,252 Added 24.64%	2,560,644 $265 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $36.1 Million - $42.6 Million	439,075 Added 27.18%	2,054,392 $174 Million
Q2 2022 Aug 11, 2022	BUY	$71.48 - $86.85 $1.75 Million - $2.13 Million	24,508 Added 1.54%	1,615,317 $134 Million
Q1 2022 May 11, 2022	BUY	$74.28 - $92.69 $22.1 Million - $27.5 Million	296,868 Added 22.94%	1,590,809 $123 Million
Q4 2021 Feb 10, 2022	SELL	$71.72 - $91.47 $117 Million - $150 Million	-1,635,035 Reduced 55.82%	1,293,941 $114 Million
Q3 2021 Nov 12, 2021	BUY	$74.77 - $85.47 $219 Million - $250 Million	2,928,976 New	2,928,976 $226 Million

Others Institutions Holding BMRN

# of Institutions

636

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.6B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Biomarin Pharmaceutical Inc Transaction History